The Market
The transcatheter mitral valve replacement market is facing substantial growth in the near future [1], estimated at 15B USD.
2%
MR patients referred to surgery
This is the percentage of MR patients referred to Mitral Valve surgery, annually. The remaining 98% are deemed inoperable due to high-risk of surgical morbidity, and are left without an optimal solution [3].
4M
MR Patients in he US
More than 4 million people in the U.S. suffer from mitral regurgitation, with around 50,000 new cases annually [1].
15B
MVR Market Estimate
Due to rise in incidences of valvular heart diseases worldwide, along with increasing demand for less invasive procedures is propelling the industry growth. Growing geriatric population suffering from heart valve diseases is leading to increase in valve replacement surgeries [2].
References:
-
BCC Publishing March 2021 Report Code HLC204B; STS ACSD ATS 2020;109:1646-55